Back to Search Start Over

COVID-19 Vaccination Campaign among the Health Workers of Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Cost–Benefit Analysis

Authors :
Nurchis, Mario Cesare
Lontano, Alberto
Pascucci, Domenico
Sapienza, Martina
Marziali, Eleonora
Castrini, Francesco
Messina, Rosaria
Regazzi, Luca
Causio, Francesco Andrea
Di Pilla, Andrea
Vetrugno, Giuseppe
Damiani, Gianfranco
Laurenti, Patrizia
Nurchis, Mario Cesare (ORCID:0000-0002-9345-4292)
Pascucci, Domenico (ORCID:0000-0002-5804-2284)
Vetrugno, Giuseppe (ORCID:0000-0003-0181-2855)
Damiani, Gianfranco (ORCID:0000-0003-3028-6188)
Laurenti, Patrizia (ORCID:0000-0002-8532-0593)
Nurchis, Mario Cesare
Lontano, Alberto
Pascucci, Domenico
Sapienza, Martina
Marziali, Eleonora
Castrini, Francesco
Messina, Rosaria
Regazzi, Luca
Causio, Francesco Andrea
Di Pilla, Andrea
Vetrugno, Giuseppe
Damiani, Gianfranco
Laurenti, Patrizia
Nurchis, Mario Cesare (ORCID:0000-0002-9345-4292)
Pascucci, Domenico (ORCID:0000-0002-5804-2284)
Vetrugno, Giuseppe (ORCID:0000-0003-0181-2855)
Damiani, Gianfranco (ORCID:0000-0003-3028-6188)
Laurenti, Patrizia (ORCID:0000-0002-8532-0593)
Publication Year :
2022

Abstract

Vaccinations generate health, economic and social benefits in both vaccinated and unvaccinated populations. The aim of this study was to conduct a cost–benefit analysis to estimate the costs and benefits associated with the COVID-19 vaccination campaign for health workers in Fondazione Policlinico Universitario Agostino Gemelli IRCCS (FPG). The analysis included 5152 healthcare workers who voluntarily received the Pfizer–BioNTech COVID-19 vaccine, divided into physicians, nurses and other health workers. Data about vaccine cost, administration and materials were derived from administrative databases of the FPG from 28 December 2020 to 31 March 2021. The costs associated with the COVID-19 vaccination campaign amounted to EUR 2,221,768, while the benefits equaled EUR 10,345,847. The benefit-to-cost ratio resulted in EUR 4.66, while the societal return on investment showed a ratio of EUR 3.66. The COVID-19 vaccination campaign for health workers in FPG has high social returns and it strengthens the need to inform and update decision-making about the economic and social benefits associated with a vaccination campaign. Health economic evaluations on vaccines should always be considered by decision-makers when considering the inclusion of a new vaccine into the national program.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1355236542
Document Type :
Electronic Resource